APLN and cardiomyopathy: Reduced circulating apelin levels have been observed in patients with heart failure, coronary artery disease and lone atrial fibrillation as well as in experimental models of isoproterenol-induced cardiomyopathy, I/R heart injury and heart failure [11, 32–36].